Preliminary results of a phase i/ii study of simultaneous boost irradiation radiotherapy for locally advanced nasopharyngeal carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7569-7576

  Xiang, Li ^a,b   Wang, Yan ^a   Xu, Bing Qing ^a   Wu, Jing Bo ^b   Xia, Yun Fei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Locally advanced nasopharyngeal carcinoma; Simultaneous boost irradiation radiotherapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; NASOPHARYNX CARCINOMA; NASOPHARYNX TUMOR; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; REMISSION; SURVIVAL RATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHEMORADIOTHERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL RATE; YOUNG ADULT;

EID: 84893346330     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7569     Document Type: Article

References (42)

1. Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The European Organization for Research and Treatment of Cancer QLQ-C30, a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76.
2. Chau RM, Teo PM, Choi PH (2001). Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol, 58, 143-53.
3. Chau RM, Teo PM, Kam MK (2007). Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim, 32, 263-70.
4. Chen HH; Tsai ST; Wang MS (2006). Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 66, 1408-14.
5. Cmelak AJ, Cox RS, Adler JR (1997). Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 37, 997-1003.
6. Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 13, 1341-6.
7. Cuihttp://item.taobao.com/item.htm?spm=a1z10.5.w4002-1294787290.52.pXxH6m&id=35391177527 NJ; Zhao CH; Hu YH, et al (1992). Influence factors of local recurrences of nasopharyngeal carcinoma (NPC)and the results of re-irradiation-an analysis of 214 patients. Chinese journal of cancer, 11, 375-79.
8. Dimery IW, Peters LJ, Goepfert H, et al (1993). Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol, 11, 1919-28.
9. Fleming ID, Cooper JS, Henson DE (2002). American Joint Committee on Cancer: AJCC Cancer Staging Manual. New York, NY: Springer-Verlag.
10. GraffP, Lapeyre M, Desandes E (2007). Impact of intensitymodulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys, 67, 1309-17.
11. Hara W, Loo BW Jr (2008). Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 71, 393-400.
12. Huang XB, Xia YF, He ZC, et al (2008). Three-Dimensional dosimetric evaluation of split-filling and simultaneous boost irradiation in radiotherapy for local advanced nasopharyngeal carcinoma. J Sun Yat-Sen Univ, 29, 303-11.
13. Johnson FM, Garden AS, Palmer JL (2005). A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 63, 717-24.
14. Kam MK, Chau RM, Suen J, et al (2003). Intensity-modulated radiotherapy in nasopharyngeal carcinoma, dosimetric advantage over conventional plans and feasibility of dose escalation [J]. Int J Radiat Oncol Biol Phys, 56, 145-57.
15. Kam MK, Teo PM, Chau RM, et al (2004). Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy, the Hong Kong experience [J]. Int J Radiat Oncol Biol Phys, 60, 1440-50.
16. Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observation. J Am Stat Assoc, 53, 457-81.
17. Kim K; Wu HG, Kim HJ (2009). Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Head Neck, 31, 1121-8.
18. Kwong DL, Sham JS, Chua DT (1997). The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 39, 703-10.
19. Kwong DL, Sham JS, Leung LH (2006). Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 64, 374-81.
20. Lai SZ, Li WF, Chen L (2010). How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients? Int J Radiat Oncol Biol Phys, 1-8.
21. Le QT, Tate D, Koong A (2003). Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 56, 1046-54.
22. Lee AW, Sze WM, Au JS (2005). Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys, 61, 1107-16.
23. Lee AW; Sze WM; Yau TK (2001). Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiother Oncol, 58, 121-30.
24. Lee N, Xia P, Quivey JM, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma, an update of the UCSF experience [J]. Int J Radiat Oncol Biol Phys, 53, 12-22.
25. Li ZQ, Xia YF, Liu Q (2006). Radiotherapy-related typing in 842 patients in canton with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 66, 1011-6.
26. Lin S, Pan J, Han L (2009). Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys, 75, 1071-8.
27. Lu H, Peng L, Yuan X, et al (2009). Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev, 35, 345-53.
28. Lu H, Yao M (2008). The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev, 34, 27-36.
29. Lu TX, Mai WY, Bin ST, et al (2001). Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy [J]. Int J Radiat Oncol Biol Phys, 51, 589-98.
30. Rades D; Fehlauer F; Wroblesky J (2007). Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol, 43, 535-43.
31. Sobin LH, Wittekind CH (2002). International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. New York, NY: Wiley-Liss.
32. Teo PM, Leung SF, Chan AT (2000). Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys, 48, 1311-22.
33. Teo PM, Leung SF, Tung SY (2006). Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol, 79, 27-33.
34. Wolden SL, Chen WC, Pfister DG (2006). Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys, 64, 57-62.
35. Wolden SL; Zelefsky MJ; Kraus DH (2001). Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol, 19, 1105-10.
36. Wong FC, Ng AW, Lee VH (2010). Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 76, 138-45.
37. Wu HB, Wang QS, Wang MF (2011). Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT. J Nucl Med, 52, 342-6.
38. Xiao WW, Huang SM, Han F (2010). Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: longterm results of a phase 2 study. Cancer, 117, 1874-83.
39. Xie GF, Cao KJ, Li Y (2005). Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma. Chin J Cancer, 24, 1246-8.
40. Yeh SA; Tang Y; Lui CC (2005). Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys, 62, 672-9.
41. Yin WB, Yu ZH, Xu GZ (2008). Radiation Oncology. Peking Union Medical College Press, BeiJing, 458.
42. Yu KH, Leung SF, Tung SY (2005). Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck, 27, 397-405.